Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.46EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.38.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.38.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.38.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.38.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.80ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.80EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.80EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.134EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.134ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used